Research Article
Upper Gastrointestinal Tract Video Capsule as an Alternative to Oesophago-Gastro-Duodenoscopy in Clinical Practice
Table 2
Outcomes following UGI capsule% (
).
| Discharged back to referral source | 48% (60) |
| UBT to exclude H. pylori | 24% (30) | OGD for follow up/histological assessment | 17% (22) | Indications for OGD % () | | Oesophagitis follow up | 22% (5) | Gastric ulcer follow up | 22% (5) | Altered blood visualised | 13% (3) | Persistent symptoms | 9% (2) | Antral submucosal lesion | 4% (1) | OGJ lesion | 4% (1) | Barrett’s oesophagus for histology | 5% (1) | Eosinophilic oesophagitis characteristics | 9% (2) | Severe gastritis | 5% (3) | Oesophageal candidiasis | 4% (1) | Outpatient clinic referral for symptoms review | 7% (9) | Medication prescribed | 6% (8) | Barium swallow | 1% (1) | Repeat UGI VCE due to assess healing | 1% (1) |
|
|
Urea breath test (UBT): proton pump inhibitor (PPI): oesophago-gastro-duodenoscopy (OGD).
|